60 patents currently held
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2028. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
3
Ending by 2030
Sep 2028
Next term end
32
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than Nov 2034 · Medium confidence
Also notable
Ends Sep 2028 · High confidence
Also notable
Ends Dec 2036 · High confidence
Asymmetric Ionizable Cationic Lipid for RNA Delivery
US 9,365,610
Cited by 38 later US patents, top 10% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2034. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Hydroxymethyl Substituted RNA Oligonucleotides and RNA Complexes
US 8,314,227
The most cited patent in this portfolio, cited by 51 later US patents, top 25% of utility patents granted in 2012 in our data. Protection runs to 2028.
Ionizable Cationic Lipid for RNA Delivery
US 10,383,952
Cited by 21 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 9 to 27, 2026 · next Dec 9
- 3 fees due Feb 6 to 28, 2027 · next Feb 6
- 4 fees due Mar 3 to 24, 2027 · next Mar 3
- 1 fee due May 26, 2027The maintenance fee for Trinucleotide Mrna Cap Analogs (US 10,487,105) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
- 1 fee due Jun 30, 2027The maintenance fee for Therapeutic Una Oligomers and Uses Thereof (US 10,519,447) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Jul 7, 2027The maintenance fee for Ionizable Cationic Lipid for RNA Delivery (US 10,526,284) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Ionizable Cationic Lipid for RNA Delivery (US 10,556,861) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
- 4 fees due Sep 26 to 30, 2027 · next Sep 26
Recent changes
- 2 of the patents on this record were granted since Aug 18, 2026
What they patent
The 5 largest of its 32 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Asymmetric Ionizable Cationic Lipid for RNA Delivery | 12 in force | to Dec 2037 |
| Ionizable Cationic Lipid for RNA Delivery (2017) | 3 in force | to Feb 2041 |
| Ionizable Cationic Lipid for RNA Delivery (2016) | 3 in force | to Dec 2036 |
| Nucleic Acids and Methods of Treatment for Cystic Fibrosis | 2 in force | to Jul 2042 |
| Compositions and Methods for Inducing Immune Responses | 2 in force | to Dec 2041 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,314,227 | Hydroxymethyl Substituted RNA Oligonucleotides and RNA Complexes In force · High confidence | In force | High confidence | |
| US 9,051,570 | Una Oligomers for Therapeutics In force · High confidence | In force | High confidence | |
| US 9,340,789 | Una Oligomer Structures for Therapeutic Agents In force · High confidence | In force | High confidence | |
| US 9,365,610 | Asymmetric Ionizable Cationic Lipid for RNA Delivery In force · Medium confidence | In force | Medium confidence | |
| US 9,580,711 | Lipid Particles with Asymmetric Cationic Lipids for RNA Delivery In force · Medium confidence | In force | Medium confidence | |
| US 9,670,152 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | In force | High confidence | |
| US 9,850,202 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | In force | High confidence | |
| US 9,896,413 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | In force | High confidence | |
| US 9,951,002 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | In force | High confidence | |
| US 10,399,937 | Ionizable Cationic Lipid for RNA Delivery In force · High confidence | In force | High confidence |
Also on record, not counted in the 60: 6 patents in force now held by others · 4 patents ended · 31 applications pending · 11 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.